VENTOLIN
Total Payments
$1.2M
Transactions
224
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $1.1M | 204 | 0 |
| 2023 | $73,556 | 6 | 0 |
| 2022 | $24,234 | 7 | 0 |
| 2020 | $6,248 | 5 | 0 |
| 2019 | $3,315 | 2 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.2M | 224 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, MULTI-CENTER STUDY TO EVAL | GlaxoSmithKline, LLC. | $1.1M | 0 |
| 207661 | GlaxoSmithKline, LLC. | $38,489 | 0 |
| 0000000000000000000000000000000000000000000000000000000000000000213289 | GlaxoSmithKline, LLC. | $30,710 | 0 |
| 208071 | GlaxoSmithKline, LLC. | $25,089 | 0 |
| 0000000000000000000000000000000000000000000000000000000000000000208071 | GlaxoSmithKline, LLC. | $24,234 | 0 |
Top Doctors Receiving Payments for VENTOLIN
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | New York, NY | $1.2M | 224 |
Ad
Manufacturing Companies
- GlaxoSmithKline, LLC. $1.2M
Product Information
- Type Drug
- Total Payments $1.2M
- Total Doctors 0
- Transactions 224
About VENTOLIN
VENTOLIN is a drug associated with $1.2M in payments to 0 healthcare providers, recorded across 224 transactions in the CMS Open Payments database. The primary manufacturer is GlaxoSmithKline, LLC..
Payment data is available from 2019 to 2024. In 2024, $1.1M was paid across 204 transactions to 0 doctors.
The most common payment nature for VENTOLIN is "Unspecified" ($1.2M, 100.0% of total).
VENTOLIN is associated with 5 research studies, including "A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, MULTI-CENTER STUDY TO EVAL" ($1.1M).